I-MAB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.56 EUR | -0.64% |
|
0.00% | -5.45% |
| 06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| 06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
d6f5a.BPjvgm_8_nQi_Ae_CXi9dpT6d5e3xzEeHliSLGHw7tI.VI294yuLrAEVsm_VRTbaJae1Df3HmHpEeCvbaAOT151VsIu7GrarLRuoXg~1dd611af9ad6da91ded60e755ab2ba94
